Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

11501

1

Vital Farms, Inc. Vital Farms Reports 31% Revenue Growth, Net Income Increase in Latest Quarter

Via official filing (AI summary) | 8 months ago | 0 comments

11502

1

SHENANDOAH TELECOMMUNICATIONS CO/VA/ Shenandoah Telecommunications Reports Significant Financial Developments, Including 30% Revenue Growth and Net Loss in Latest Quarter

Via official filing (AI summary) | 8 months ago | 0 comments

11503

1

NCR VOYIX Corp NCR Voyix Reports 12% Revenue Decline, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 8 months ago | 0 comments

11504

1

Jasper Therapeutics, Inc. Jasper Therapeutics Reports Third Quarter Financial Results, Net Loss of $18.6 Million

Via official filing (AI summary) | 8 months ago | 0 comments

11505

1

Rapport Therapeutics, Inc. Rapport Therapeutics Reports Financial Results, Advances Lead Product Candidate RAP-219

Via official filing (AI summary) | 8 months ago | 0 comments

11506

1

Applied Therapeutics Inc. Applied Therapeutics Reports Significant Cash Increase, Revenue Growth, and Net Loss in Latest Quarter

Via official filing (AI summary) | 8 months ago | 0 comments

11507

1

Vigil Neuroscience, Inc. Vigil Neuroscience Reports Q3 Financial Results, Net Loss of $19.3M

Via official filing (AI summary) | 8 months ago | 0 comments

11508

1

Akebia Therapeutics, Inc. Akebia Therapeutics Reports 11% Revenue Decline, Increased Net Losses in Q3 2024

Via official filing (AI summary) | 8 months ago | 0 comments

11509

1

Q32 Bio Inc. Q32 Bio Reports Significant Financial Changes Following Merger, Anticipates Continued Losses

Via official filing (AI summary) | 8 months ago | 0 comments

11510

1

Cartesian Therapeutics, Inc. Cartesian Therapeutics Reports Decline in Revenue, Net Loss, and Increased Cash Reserves in Latest 10-Q Filing

Via official filing (AI summary) | 8 months ago | 0 comments

11511

1

CHIMERIX INC Chimerix Reports Mixed Financial Results, Focuses on Lead Product Development

Via official filing (AI summary) | 8 months ago | 0 comments

11512

1

Cullinan Therapeutics, Inc. Cullinan Therapeutics Reports Improved Financial Position, Net Loss in Latest Quarter

Via official filing (AI summary) | 8 months ago | 0 comments

11513

1

DIEBOLD NIXDORF, Inc Diebold Nixdorf Reports Revenue Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | 8 months ago | 0 comments

11514

1

Repare Therapeutics Inc. Repare Therapeutics Reports Q3 Financial Results, Net Loss Improves Amid Strategic Reprioritization and Reduced Expenses

Via official filing (AI summary) | 8 months ago | 0 comments

11515

1

TREVENA INC Trevena Reports Significant Financial Changes, Net Loss Improvement, and Strategic Adjustments in 10-Q Filing

Via official filing (AI summary) | 8 months ago | 0 comments

11516

1

DUCOMMUN INC /DE/ Ducommun Incorporated Reports Strong Q3 and Nine-Month Financial Results with Revenue and Profitability Growth

Via official filing (AI summary) | 8 months ago | 0 comments

11517

1

BEYOND MEAT, INC. Beyond Meat Reports Mixed Q3 Results, Net Loss Narrows Amid Cost Reductions and Operational Challenges

Via official filing (AI summary) | 8 months ago | 0 comments

11518

1

Vivid Seats Inc. Vivid Seats Reports Mixed Q3 Results with Revenue Growth, Declining Profitability

Via official filing (AI summary) | 8 months ago | 0 comments

11519

1

Village Farms International, Inc. Village Farms International Reports 20% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 8 months ago | 0 comments

11520

1

Orthofix Medical Inc. Orthofix Medical Reports 6.8% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 8 months ago | 0 comments

11521

1

MidCap Financial Investment Corp MidCap Financial Investment Corporation Reports Strong Growth in Investment Income and Assets, Despite Rising Debt Costs

Via official filing (AI summary) | 8 months ago | 0 comments

11522

1

Zura Bio Ltd Zura Bio Reports Significant Financial Developments, Including 90% Increase in Operating Expenses and $188.2 Million in Cash and Cash Equivalents

Via official filing (AI summary) | 8 months ago | 0 comments

11523

1

Monte Rosa Therapeutics, Inc. Monte Rosa Therapeutics Reports Increased Collaboration Revenue and Reduced Losses, Enters Strategic Partnerships

Via official filing (AI summary) | 8 months ago | 0 comments

11524

1

First Watch Restaurant Group, Inc. First Watch Restaurant Group Reports 14.8% Revenue Growth, Net Income Decline in Q3 2024

Via official filing (AI summary) | 8 months ago | 0 comments

11525

1

MoonLake Immunotherapeutics MoonLake Immunotherapeutics Reports Significant Financial Developments, Net Loss Increases 210.8% in Latest Quarter

Via official filing (AI summary) | 8 months ago | 0 comments